Evolent Health, Inc. (EVH) |
| 4.8 0.22 (4.8%) 06-12 16:00 |
| Open: | 4.72 |
| High: | 4.905 |
| Low: | 4.56 |
| Volume: | 2,106,438 |
| Market Cap: | 540(M) |
| PE Ratio: | -1.03 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Healthcare Information Services |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 5.73 |
| Resistance 1: | 4.91 |
| Pivot price: | 4.21 |
| Support 1: | 4.14 |
| Support 2: | 3.67 |
| 52w High: | 12.065 |
| 52w Low: | 2.095 |
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
| EPS | -4.680 |
| Book Value | 3.520 |
| PEG Ratio | 1.93 |
| Gross Profit | 3.389 |
| Profit Margin (%) | -26.29 |
| Operating Margin (%) | -2.04 |
| Return on Assets (ttm) | -0.4 |
| Return on Equity (ttm) | -65.1 |
Thu, 07 May 2026
Evolent Health (NYSE:EVH) Misses Q1 CY2026 Revenue Estimates, But Stock Soars 5.1% - Yahoo Finance
Thu, 07 May 2026
Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Thu, 07 May 2026
Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Sat, 25 Apr 2026
Why Evolent Health (EVH) Stock Is Up Today - Yahoo Finance
Tue, 07 Apr 2026
Evolent Health (EVH): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Mon, 09 Feb 2026
Evolent Health (EVH): From ACA Headwinds to Specialty Care Expansion - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |